ArticleJournal of clinical epidemiology2013

Different analyses estimate different parameters of the effect of erythropoietin stimulating agents on survival in end stage renal disease: a comparison of payment policy analysis, instrumental variables, and multiple imputation of potential outcomes.

David D Dore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.